NRD
TDOC icon

Nebula Research & Development’s Teladoc Health TDOC Stock Holding History

Nebula Research & Development’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-31,446
Closed -$308K – 1162
2024
Q2 		$308K Sell
31,446
-18,678
-37% -$228K 0.05% 604
2024
Q1 		$757K Buy
+50,124
New +$910K 0.16% 220
2023
Q2 		– Sell
-10,319
Closed -$267K – 447
2023
Q1 		$267K Buy
+10,319
New +$276K 0.47% 128

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Nebula Research & Development's TDOC Position: Q3 2024 in Review

Nebula Research & Development sold out of Teladoc Health (TDOC) in Q3 2024, closing a stake of 31,446 shares — an estimated $308K sold.

Nebula Research & Development first reported a position in TDOC in Q1 2023 and held it in 3 quarters. The position peaked at $757K in Q1 2024. 366 funds tracked by Wall St. Rank hold TDOC as of Q3 2024.

  • Nebula Research & Development reported no remaining Teladoc Health position as of Q3 2024 after selling out during the quarter.
  • Nebula Research & Development sold 31,446 Teladoc Health shares in Q3 2024, an estimated $308K.
  • Nebula Research & Development first reported a position in Teladoc Health in Q1 2023 and held it in 3 quarters.
  • Nebula Research & Development's Teladoc Health position peaked at $757K in Q1 2024.
  • 366 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2024.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.